New patent expiration for Novartis drug AMTURNIDE – DrugPatentWatch
Annual Drug Patent Expiration for AMTURNIDE
Amturnide is a drug marketed by Novartis and included in one NDA. There is one patent protecting this drug.
This drug has twenty-nine patent family members in twenty-four countries.
The generic ingredient in AMTURNIDE is aliskiren hemifumarate; amlodipine besylate; hydrochlorothiazide. Additional details are available on aliskiren hemifumarate; amlodipine besylate; hydrochlorothiazide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published on Recently expired patent for the Novartis drug AMTURNIDE
